Twist Bioscience (TWST) Stock: Buy, Sell, or Hold?
TWST - Twist Bioscience Corporation Common Stock
$188.67
0.62 (0.33%)
▲
5d:
+3.19%
30d:
+44.02%
90d:
+88.8%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 13, 2026
Get Alerted When TWST Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: TWST shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: TWST shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: TWST is currently trading at $188.67, which is considered extended relative to its 30-day fair value range of $130.40 to $175.11.
Technical Outlook: Technically, TWST is in a strong uptrend. Immediate support is located at $156.83, while resistance sits at $200.31.
Market Sentiment: TWST scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $112.08. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, TWST is in a strong uptrend. Immediate support is located at $156.83, while resistance sits at $200.31.
Market Sentiment: TWST scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $112.08. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$130.40 -
$175.11
Company Quality Score
32/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
10.5%
Protect Your Profits
TWST is technically overbought (RSI 71). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+7.7% above its trading range)
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 40.6% above Wall St target ($112.08)
- WARNING: Composite score 32/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$130.40 -
$175.11
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$156.83
Resistance Level
$200.31
Current Trend
Strong Uptrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-251.02
Wall Street Target
$112.08
(-40.6%)
Revenue Growth (YoY)
23.2%
Profit Margin
-31.7%
Share & Embed Analysis
Last updated: October 02, 2026 9:06 PM ET
Data refreshes hourly during market hours. Next update: 10:06 PM
Data refreshes hourly during market hours. Next update: 10:06 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TWST showing a specific setup today?
Insider Activity (6 Months)
0
Buys
5
Sells
Net
INSIDERS SELLING
Recent Transactions
Emily M Leproust
SELL
8061 shares
2026-04-22
Emily M Leproust
SELL
1610 shares
2026-04-21
Adam Laponis
SELL
4000 shares
2026-04-17
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$371 | 49 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$433 | 56 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$570 | 55 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$310 | 66 BUY |
|
CLDX
Celldex Therapeutics Inc |
STRONG BUY
15 analysts |
$63 | 60 BUY |
Advanced TWST Option Strategies
Professional options setups generated by AI based on today's TWST price and gamma walls.
